In a report released today, Stephen Willey from Stifel Nicolaus maintained a Buy rating on Geron (GERN – Research Report), with a price target ...

Fintel reports that on December 6, 2024, BMO Capital initiated coverage of IGM Biosciences (NasdaqGS:IGMS) with a Outperform ...

BMO Capital initiated coverage of IGM Biosciences (IGMS) with an Outperform rating and $21 price target IGM is a clinical-stage biotechnology ...

IGM Biosciences has pivoted from cancer therapeutics to autoimmune diseases despite setbacks, showing a 25% stock increase since last October. Click for more on IGMS.

Quest Partners LLC lessened its stake in IGM Biosciences, Inc. (NASDAQ:IGMS – Free Report) by 86.2% in the 3rd quarter, ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Metrion Biosciences (“Metrion”), the specialist preclinical contract research organization (CRO) and a leader in ion channel screening, today announced the appointment of Lee Patterson as its ...

Freya Biosciences (Freya or the Company), a transatlantic biotech company specializing in women's health, today announces a $10.4 million strategic investment from the Bill & Melinda Gates ...

Harmony Biosciences is a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases who have unmet medical needs.